Follow
Huseyin Naci
Title
Cited by
Cited by
Year
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study
H Naci, JPA Ioannidis
Bmj 347, f5577, 2013
9382013
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals …
C Davis, H Naci, E Gurpinar, E Poplavska, A Pinto, A Aggarwal
bmj 359, 2017
6442017
Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers
JP Jansen, H Naci
BMC medicine 11, 1-8, 2013
5602013
From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management
E Mossialos, E Courtin, H Naci, S Benrimoj, M Bouvy, K Farris, P Noyce, ...
Health policy 119 (5), 628-639, 2015
4962015
Distribution of road traffic deaths by road user group: a global comparison
H Naci, D Chisholm, TD Baker
Injury prevention 15 (1), 55-59, 2009
4492009
Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials
H Naci, J Brugts, T Ades
Circulation: Cardiovascular Quality and Outcomes 6 (4), 390-399, 2013
4012013
How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on …
H Naci, M Salcher-Konrad, S Dias, MR Blum, SA Sahoo, D Nunan, ...
British journal of sports medicine 53 (14), 859-869, 2019
3072019
Economic burden of multiple sclerosis: a systematic review of the literature
H Naci, R Fleurence, J Birt, A Duhig
Pharmacoeconomics 28, 363-379, 2010
2792010
Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and …
H Naci, JJ Brugts, R Fleurence, B Tsoi, H Toor, AE Ades
european Journal of preventive Cardiology 20 (4), 641-657, 2013
2332013
Characteristics of preapproval and postapproval studies for drugs granted accelerated approval by the US Food and Drug Administration
H Naci, KR Smalley, AS Kesselheim
Jama 318 (7), 626-636, 2017
1842017
Evaluation of Wellness Determinants and Interventions by Citizen Scientists
H Naci, JPA Ioannidis
JAMA 350, h1323, 2015
1692015
Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence?
E Mossialos, H Naci, E Courtin
Health policy 111 (2), 135-148, 2013
1272013
Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional …
H Naci, C Davis, J Savović, JPT Higgins, JAC Sterne, B Gyawali, ...
bmj 366, 2019
1262019
Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study
D Chisholm, H Naci, AA Hyder, NT Tran, M Peden
Bmj 344, 2012
1092012
Prognostic significance of left ventricular noncompaction: systematic review and meta-analysis of observational studies
N Aung, S Doimo, F Ricci, MM Sanghvi, C Pedrosa, SP Woodbridge, ...
Circulation: Cardiovascular Imaging 13 (1), e009712, 2020
1002020
How good is “evidence” from clinical studies of drug effects and why might such evidence fail in the prediction of the clinical utility of drugs?
H Naci, JPA Ioannidis
Annual review of pharmacology and toxicology 55, 169-189, 2015
912015
The critical role of observational evidence in comparative effectiveness research
RL Fleurence, H Naci, JP Jansen
Health Affairs 29 (10), 1826-1833, 2010
852010
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology
N Jackson, D Atar, M Borentain, G Breithardt, M van Eickels, M Endres, ...
European heart journal 37 (9), 747-754, 2016
832016
Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials
H Naci, JJ Brugts, R Fleurence, AE Ades
European journal of preventive cardiology 20 (4), 658-670, 2013
812013
Cost implications of using different ECG criteria for screening young athletes in the United Kingdom
H Dhutia, A Malhotra, V Gabus, A Merghani, G Finocchiaro, L Millar, ...
Journal of the American College of Cardiology 68 (7), 702-711, 2016
802016
The system can't perform the operation now. Try again later.
Articles 1–20